A citation-based method for searching scientific literature

Ashley M Zurek, Raghunandan Yendapally, Elizabeth M Urteaga. Diabetes Spectr 2017
Times Cited: 4







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Effect of dog-walking on autonomic nervous activity in senior citizens.
Masahiko Motooka, Hiroto Koike, Tomoyuki Yokoyama, Nell L Kennedy. Med J Aust 2006
45
25


Can the cold pressor test predict future cardiovascular events in patients without demonstrated ischemic heart disease by SPECT?
Enrique Pautasso, Martin Koretzky, Leopoldo Marcon, Carlos Borrego, Julio Panini, Jorge Lerman. Int J Cardiol 2014
9
25

Cardiac Autonomic Neuropathy in Diabetes: A Predictor of Cardiometabolic Events.
Aaron I Vinik, Carolina Casellini, Henri K Parson, Sheri R Colberg, Marie-Laure Nevoret. Front Neurosci 2018
37
25

Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association.
Sheri R Colberg, Ronald J Sigal, Jane E Yardley, Michael C Riddell, David W Dunstan, Paddy C Dempsey, Edward S Horton, Kristin Castorino, Deborah F Tate. Diabetes Care 2016
769
25

Diabetic Neuropathy: A Position Statement by the American Diabetes Association.
Rodica Pop-Busui, Andrew J M Boulton, Eva L Feldman, Vera Bril, Roy Freeman, Rayaz A Malik, Jay M Sosenko, Dan Ziegler. Diabetes Care 2017
632
25

Risk Factors for the Presence and Progression of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: ADDITION-Denmark.
Signe T Andersen, Daniel R Witte, Jesper Fleischer, Henning Andersen, Torsten Lauritzen, Marit E Jørgensen, Troels S Jensen, Rodica Pop-Busui, Morten Charles. Diabetes Care 2018
29
25

Diabetic autonomic neuropathy.
Aaron I Vinik, Raelene E Maser, Braxton D Mitchell, Roy Freeman. Diabetes Care 2003
25

Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment.
Victoria A Serhiyenko, Alexandr A Serhiyenko. World J Diabetes 2018
54
25

Anemia, bilirubin, and cardiovascular autonomic neuropathy in patients with type 2 diabetes.
Jin Ook Chung, Seon-Young Park, Dong Hyeok Cho, Dong Jin Chung, Min Young Chung. Medicine (Baltimore) 2017
9
25

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management.
Arun Chaudhury, Chitharanjan Duvoor, Vijaya Sena Reddy Dendi, Shashank Kraleti, Aditya Chada, Rahul Ravilla, Asween Marco, Nawal Singh Shekhawat, Maria Theresa Montales, Kevin Kuriakose,[...]. Front Endocrinol (Lausanne) 2017
315
25

Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners.
Ramzi Ajjan, David Slattery, Eugene Wright. Adv Ther 2019
18
25

Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives.
Victoria L Fisher, Abd A Tahrani. Diabetes Metab Syndr Obes 2017
40
25

Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease.
Aaron I Vinik, Tomris Erbas, Carolina M Casellini. J Diabetes Investig 2013
151
25

Diabetic autonomic neuropathy.
Roy Freeman. Handb Clin Neurol 2014
52
25


The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin.
Nellowe Candelario, Jedrzej Wykretowicz. Oxf Med Case Reports 2016
20
25


Sodium-glucose Cotransporter-2 Induced Diabetic Ketoacidosis with Minimal Hyperglycemia.
D Taylor Gammons, Francis L Counselman. Clin Pract Cases Emerg Med 2018
3
33

The Ketogenic Diet for Obesity and Diabetes-Enthusiasm Outpaces Evidence.
Shivam Joshi, Robert J Ostfeld, Michelle McMacken. JAMA Intern Med 2019
41
25

Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin.
Daniel A Kelmenson, Kelsey Burr, Yusra Azhar, Paul Reynolds, Chelsea A Baker, Neda Rasouli. J Investig Med High Impact Case Rep 2017
18
25

An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus.
Daniel S Hsia, Owen Grove, William T Cefalu. Curr Opin Endocrinol Diabetes Obes 2017
96
25


AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.
Yehuda Handelsman, Robert R Henry, Zachary T Bloomgarden, Sam Dagogo-Jack, Ralph A DeFronzo, Daniel Einhorn, Ele Ferrannini, Vivian A Fonseca, Alan J Garber, George Grunberger,[...]. Endocr Pract 2016
171
25


Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma.
Prashanth Rawla, Anantha R Vellipuram, Sathyajit S Bandaru, Jeffrey Pradeep Raj. Endocrinol Diabetes Metab Case Rep 2017
24
25

SGLT2 Inhibitors: A Systematic Review of Diabetic Ketoacidosis and Related Risk Factors in the Primary Literature.
Kelly R Burke, Christine A Schumacher, Spencer E Harpe. Pharmacotherapy 2017
91
25

Acid-base safety during the course of a very low-calorie-ketogenic diet.
Diego Gomez-Arbelaez, Ana B Crujeiras, Ana I Castro, Albert Goday, Antonio Mas-Lorenzo, Ana Bellon, Cristina Tejera, Diego Bellido, Cristobal Galban, Ignacio Sajoux,[...]. Endocrine 2017
21
25

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.
Anne L Peters, Elizabeth O Buschur, John B Buse, Pejman Cohan, Jamie C Diner, Irl B Hirsch. Diabetes Care 2015
433
25


Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.
Bassam M Ayoub, Shereen Mowaka, Marwa M Safar, Nermeen Ashoush, Mona G Arafa, Haidy E Michel, Mariam M Tadros, Mohamed M Elmazar, Shaker A Mousa. Sci Rep 2018
17
25

A simple practice guide for dose conversion between animals and human.
Anroop B Nair, Shery Jacob. J Basic Clin Pharm 2016
25

Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes.
Carmen Hierro-Bujalance, Carmen Infante-Garcia, Angel Del Marco, Marta Herrera, Maria Jose Carranza-Naval, Javier Suarez, Pilar Alves-Martinez, Simon Lubian-Lopez, Monica Garcia-Alloza. Alzheimers Res Ther 2020
16
25

A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium-glucose co-transporter-2 inhibitors.
Emily Brown, Surya P Rajeev, Daniel J Cuthbertson, John P H Wilding. Diabetes Obes Metab 2019
35
25




Comparative Study Between Multivariate and Univariate Analysis of Two Antidiabetic Combinations.
Maha F Abdel-Ghany, Omar Abdel-Aziz, Miriam F Ayad, Mariam M Tadros. J AOAC Int 2017
5
25


Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice.
Byambasuren Ganbaatar, Daiju Fukuda, Masakazu Shinohara, Shusuke Yagi, Kenya Kusunose, Hirotsugu Yamada, Takeshi Soeki, Ken-Ichi Hirata, Masataka Sata. Eur J Pharmacol 2020
29
25


New spectrofluorimetric analysis of empagliflozin in its tablets and human plasma using two level full factorial design.
Mahmoud A Omar, Hytham M Ahmed, Hany A Batakoushy, Mohamed A Abdel Hamid. Spectrochim Acta A Mol Biomol Spectrosc 2020
2
50

LC-MS/MS Determination of Empagliflozin and Metformin.
Bassam M Ayoub, Shereen Mowaka. J Chromatogr Sci 2017
14
25



Pharmacokinetic Evaluation of Empagliflozin in Healthy Egyptian Volunteers Using LC-MS/MS and Comparison with Other Ethnic Populations.
Bassam M Ayoub, Shereen Mowaka, Eman S Elzanfaly, Nermeen Ashoush, Mohamed M Elmazar, Shaker A Mousa. Sci Rep 2017
12
25





Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.